D. J. Bharali Et Al. , "Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer," NANOMEDICINE , vol.8, no.12, pp.1943-1954, 2013
Bharali, D. J. Et Al. 2013. Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. NANOMEDICINE , vol.8, no.12 , 1943-1954.
Bharali, D. J., Yalcin, M., Davis, P. J., & Mousa, S. A., (2013). Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. NANOMEDICINE , vol.8, no.12, 1943-1954.
Bharali, Dhruba Et Al. "Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer," NANOMEDICINE , vol.8, no.12, 1943-1954, 2013
Bharali, Dhruba J. Et Al. "Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer." NANOMEDICINE , vol.8, no.12, pp.1943-1954, 2013
Bharali, D. J. Et Al. (2013) . "Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer." NANOMEDICINE , vol.8, no.12, pp.1943-1954.
@article{article, author={Dhruba J. Bharali Et Al. }, title={Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer}, journal={NANOMEDICINE}, year=2013, pages={1943-1954} }